These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22025890)

  • 1. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' disease.
    Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhuri S; Saha A; Mandal LK; Bhattacharya B
    Mol Vis; 2011; 17():2552-63. PubMed ID: 22025890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.
    Urbančič M; Petrovič D; Živin AM; Korošec P; Fležar M; Petrovič MG
    Mol Vis; 2020; 26():472-482. PubMed ID: 32606566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of interferon-gamma, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms with occurrence and severity of Eales' disease.
    Sen A; Paine SK; Chowdhury IH; Mondal LK; Mukherjee A; Biswas A; Chowdhury S; Bhattacharya S; Bhattacharya B
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):171-8. PubMed ID: 20720222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.
    Ambreen F; Ismail M; Qureshi IZ
    Mol Vis; 2015; 21():985-99. PubMed ID: 26330749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic potential of vitreous from Proliferative Diabetic Retinopathy and Eales' Disease patients.
    Murugeswari P; Shukla D; Kim R; Namperumalsamy P; Stitt AW; Muthukkaruppan V
    PLoS One; 2014; 9(10):e107551. PubMed ID: 25310689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.
    Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhury S; Mandal LK; Bhattacharya B
    Retina; 2011; 31(7):1412-20. PubMed ID: 21394064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory cytokines and angiogenic and antiangiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease (ED).
    Querques G; Delle Noci N
    Retina; 2009 Jan; 29(1):121-3; author reply 123. PubMed ID: 18936719
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of IL-6 promoter polymorphism hotspots (- 174G/C and - 572G/C) with cardiovascular disease risk factors.
    Tabrez S; Jabir NR; Zughaibi TA; Suhail M
    Mol Biol Rep; 2022 Mar; 49(3):2265-2272. PubMed ID: 35023009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
    Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Harino S; Hori S
    Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales' Disease.
    Ersöz MG; Hocaoğlu M; Sayman Muslubaş IB; Arf S; Karaçorlu M
    Turk J Ophthalmol; 2021 Apr; 51(2):102-106. PubMed ID: 33951898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of inflammatory factors with macular edema in branch retinal vein occlusion.
    Noma H; Mimura T; Eguchi S
    JAMA Ophthalmol; 2013 Feb; 131(2):160-5. PubMed ID: 23411880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter polymorphisms in IL-6 gene influence pro-inflammatory cytokines for the risk of osteoarthritis.
    Singh M; Mastana S; Singh S; Juneja PK; Kaur T; Singh P
    Cytokine; 2020 Mar; 127():154985. PubMed ID: 31951965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
    Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis.
    Rocha S; Valente MJ; Coimbra S; Catarino C; Rocha-Pereira P; Oliveira JG; Madureira J; Fernandes JC; do Sameiro-Faria M; Miranda V; Belo L; Santos-Silva A; Bronze-da-Rocha E
    Sci Rep; 2021 Jul; 11(1):14768. PubMed ID: 34285273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.
    Zakharyan R; Petrek M; Arakelyan A; Mrazek F; Atshemyan S; Boyajyan A
    Tissue Antigens; 2012 Aug; 80(2):136-42. PubMed ID: 22571276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eales' disease: increased oxidation and peroxidation products of membrane constituents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous.
    Sulochana KN; Biswas J; Ramakrishnan S
    Curr Eye Res; 1999 Sep; 19(3):254-9. PubMed ID: 10487964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.